Lexicon Pharmaceuticals, Inc. (LXRX) Tops Q2 EPS by 1c
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) reported Q2 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
